Lataa...
Robust treatment comparison based on utilities of semi-competing risks in non-small-cell lung cancer
A design is presented for a randomized clinical trial comparing two second-line treatments, chemotherapy versus chemotherapy plus reirradiation, for treatment of recurrent non-small-cell lung cancer. The central research question is whether the potential efficacy benefit that adding reirradiation to...
Tallennettuna:
| Julkaisussa: | J Am Stat Assoc |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5607962/ https://ncbi.nlm.nih.gov/pubmed/28943681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/01621459.2016.1176926 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|